製品名:methyl 3-(methoxymethyl)-1H-pyrazole-4-carboxylate

IUPAC Name:methyl 3-(methoxymethyl)-1H-pyrazole-4-carboxylate

CAS番号:318496-66-1
分子式:C7H10N2O3
純度:95%+
カタログ番号:CM1045731
分子量:170.17

包装単位 有効在庫 価格(USD) 数量
CM1045731-250mg in stock ţǟţ
CM1045731-1g in stock ǎŁħ
CM1045731-5g in stock ţǎřƴ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:318496-66-1
分子式:C7H10N2O3
融点:-
SMILESコード:COCC1=NNC=C1C(=O)OC
密度:
カタログ番号:CM1045731
分子量:170.17
沸点:
MDL番号:
保管方法:

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.

Column Infos

Sebetralstat
KalVista Pharmaceuticals recently announces Phase 3 KONFIDENT trial of Sebetralstat meets all primary and key secondary endpoints as first oral on-demand therapy for Hereditary Angioedema (HAE). HAE is a rare and potentially life-threatening genetic disease caused by low levels or dysfunction of the C1 inhibitor, associated with uncontrolled plasma kallikrein (PKa) activity and generation of bradykinin (BK).
Sebetralstat is an investigational novel, oral plasma kallikrein inhibitor with a favorable safety profile. It works by targeting the kallikrein–kinin system (KKS), reducing the activity of plasma kallikrein and blocking uncontrolled bradykinin release in HAE attack. The Phase 3 results also show rapid symptom relief in a broad HAE population.